Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand-name drug

Cotempla price, strengths & recalls

Brand of methylphenidate (generic)

Pharmacies pay $536.32 for 30 tablets of Cotempla 17.3 mg orally disintegrating tablet this week, and from $536.32 to $540.59 across its 3 priced strengths and forms. The generic, methylphenidate, costs pharmacies from $3.65. It is in shortage (unavailable). It has 24 recalls on record, none ongoing. Its official label last changed on October 9, 2026.

UnavailableBrand
Pharmacies pay$536.32for 30 tablets of 17.3 mg orally disintegrating tablet-0.1% in 4 weeks
Fair cash price
$627.27
Strengths
3
Makers
1
Updated
Nov 11

Cotempla price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
8.6 mg orally disintegrating tablet Brand$18.02$540.58 / 30 tablets-0.2%+5.2%
17.3 mg orally disintegrating tablet Brand$17.88$536.32 / 30 tablets-0.1%+4.5%
25.9 mg orally disintegrating tablet Brand$17.94$538.33 / 30 tablets-0.2%+5.2%

The lowest cost per tablet is 17.3 mg orally disintegrating tablet at $17.88. Strengths aren't interchangeable - ask your pharmacist or prescriber before changing.

Cotempla vs generic methylphenidate

GenericMethylphenidate prices

Supply status: shortages & recalls

In shortage38 products are short or being discontinued
1 ongoing recall24 recalls on record

Shortages

  • Relexxii, Tablet, Extended Release, 45 mg (NDC 68025-088-30)Vertical Pharmaceuticals, LLC · Available · Updated Nov 3, 2026
  • Methylphenidate Hydrochloride, Tablet, Extended Release, 72 mg (NDC 13811-710-30)Trigen Laboratories, LLC · Limited Availability · Reason: Demand increase for the drug · Updated Nov 3, 2026Allocation to current contracted customers
  • Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-30)Vertical Pharmaceuticals, LLC · Available · Updated Nov 3, 2026
  • Relexxii, Tablet, Extended Release, 72 mg (NDC 68025-084-30)Vertical Pharmaceuticals, LLC · Available · Updated Nov 3, 2026
  • Relexxii, Tablet, Extended Release, 54 mg (NDC 68025-098-10)Vertical Pharmaceuticals, LLC · Limited Availability · Reason: Discontinuation of the manufacture of the drug · Updated Nov 3, 2026Temporary discontinuation of 100ct
  • Relexxii, Tablet, Extended Release, 18 mg (NDC 68025-095-30)Vertical Pharmaceuticals, LLC · Available · Updated Nov 3, 2026
  • Relexxii, Tablet, Extended Release, 36 mg (NDC 68025-097-10)Vertical Pharmaceuticals, LLC · Limited Availability · Reason: Discontinuation of the manufacture of the drug · Updated Nov 3, 2026Temporary discontinuation of 100ct
  • Methylphenidate Hydrochloride, Tablet, Extended Release, 63 mg (NDC 13811-700-30)Trigen Laboratories, LLC · Limited Availability · Reason: Demand increase for the drug · Updated Nov 3, 2026Allocation to current contracted customers
  • Methylphenidate Hydrochloride, Tablet, Extended Release, 18 mg (NDC 13811-706-10)Trigen Laboratories, LLC · Limited Availability · Reason: Demand increase for the drug · Updated Nov 3, 2026Allocation to current contracted customers
  • Relexxii, Tablet, Extended Release, 27 mg (NDC 68025-096-10)Vertical Pharmaceuticals, LLC · Available · Updated Nov 3, 2026
  • Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 13811-709-10)Trigen Laboratories, LLC · Limited Availability · Reason: Demand increase for the drug · Updated Nov 3, 2026Allocation to current contracted customers
  • Concerta, Tablet, Extended Release, 18 mg (NDC 50458-585-01)Janssen Pharmaceuticals · Available · Updated Nov 3, 2026

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

Showing the 6 most relevant of 24 - all recalls.

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for cotempla? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedOctober 9, 2026
Version16 of 15
EffectiveMar 2, 2026
Read the label

These highlights do not include all the information needed to use COTEMPLA XR-ODT safely and effectively. See full prescribing information for COTEMPLA XR-ODT. COTEMPLA XR-ODT (methylphenidate extended-release orally disintegrating tablets), CII Initial U.S. Approval: 1955

This drug has a boxed warning

WARNING: ABUSE, MISUSE, AND ADDICTION

COTEMPLA XR-ODT has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including COTEMPLA XR-ODT, can result in overdose and death (5.1, 9.2, 10). Before prescribing COTEMPLA XR-ODT, assess each patient's risk for abuse, misuse, and addiction. Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug. Throughout treatment, reassess each patient's risk and frequently monitor for signs and symptoms of abuse, misuse, and addiction.

WARNING: ABUSE, MISUSE, AND ADDICTION

See full prescribing information for complete boxed warning.

COTEMPLA XR-ODT has a high potential for abuse and misuse, which can lead to the development of a substance use disorder, including addiction. Misuse and abuse of CNS stimulants, including COTEMPLA XR-ODT, can result in overdose and death (5.1, 9.2, 10):

• Before prescribing COTEMPLA XR-ODT, assess each patient's risk for abuse, misuse, and addiction.

• Educate patients and their families about these risks, proper storage of the drug, and proper disposal of any unused drug.

• Throughout treatment, reassess each patient's risk and frequently monitor for signs and symptoms of abuse, misuse, and addiction.

Recent major changes (as listed on the label)

Indications and Usage (

1) 09/2025

Warnings and Precautions (

5.7) 09/2025

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA205489 · Neos Theraps Inc
First approved
June 19, 2017 (9 years ago)
Latest approved change
September 23, 2025
Approved label
PDF, Sep 25, 2025
Generic makers
31 approved generic applications on the market
Last patent listed
January 25, 2038

Cotempla questions

How much does cotempla cost without insurance?

Pharmacies pay about $536.32 for 30 tablets of cotempla 17.3 mg orally disintegrating tablet ($17.88 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $627.27. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is there a generic for Cotempla?

Yes: methylphenidate. Pharmacies pay from $3.65 for it. Compare methylphenidate prices.

Is cotempla in shortage?

Yes. 38 products are listed as in shortage or being discontinued (unavailable). See which ones.

Has cotempla been recalled?

24 recalls on record, none ongoing. Recalls name specific lots - check yours.

When did the cotempla label last change?

The official label was last updated on October 9, 2026 (version 16). See what changed.

Talk about cotempla

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.